Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-11

Clinical Trial Update: Memantine for Epileptic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 trial update for memantine in epileptic encephalopathy (childhood-onset) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: Kenneth Myers, MD | Conditions: Epileptic Encephalopathy, Childhood-Onset | Phase 4 | Status: COMPLETED